Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

47.85
Delayed Data
As of Sep 30
 +1.75 / +3.80%
Today’s Change
30.94
Today|||52-Week Range
54.96
+25.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues71.4M75.1M105.6M93.0M
 
 
 
 
 
Cost of Goods Sold24.5M18.0M16.2M17.3M
 
 
 
 
 
Depreciation And Amortization4.5M4.8M4.7M3.8M
 
 
 
 
 
 
Operating ExpensesGross Income42.4M52.3M84.7M71.9M
 
 
 
 
 
General Expenses20.1M20.0M23.2M23.8M
 
 
 
 
 
Research And Development5.4M7.1M8.1M9.0M
 
 
 
 
 
Total Operating Expenses49.1M42.8M44.1M44.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income22.3M32.3M61.4M48.1M
 
 
 
 
 
Extraordinary Credit0.00286.8K0.000.00
 
 
Extraordinary Charge-2.5M0.000.000.00
 
 
Interest Expense On Debt187.8K127.2K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income19.5M32.5M61.5M48.3M
 
 
 
 
 
Income Taxes-7.8M-11.9M-23.2M-17.5M
 
 
 
 
 
Net Income11.8M20.6M38.3M30.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.3M14.1M14.7M14.9M
 
 
 
 
 
Shares To Calculate EPS Diluted14.3M14.8M15.3M15.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.82$1.39$2.51$2.01
 
 
 
 
 
EPS Diluted$0.82$1.39$2.51$2.01